Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer

Author(s):
Paller, C.J.; Wissing, M.D.; Mendonca, J.; Sharma, A.; Kim, E.; Kim, H.S.; Kortenhorst, M.S.Q.; Gerber, S.; Rosen, M.; Shaikh, F.; Zahurak, M.L.; Rudek, M.A.; Hammers, H.; Rudin, C.M.; Carducci, M.A.; Kachhap, S.K.
Published
2014
Publication type
Article / Letter to editor
AMG 900aurora kinase inhibitorhistone deacetylase inhibitorsprostate cancersynergyvalproic acidvorinostat
Date issued
2014-10-31
Language
English
Is part of
Cancer Medicine (2014), Vol. 3, no. 5, p. 1322-1335
hdl
1887/105127
doi
10.1002/cam4.289